Preparation and properties of totally synthetic immunogens

Vaccine

Volumn 18, Issue 3-4, 1999, Pages 355-361

  Jackson, David C ^a   Fitzmaurice, Catherine J ^a   Brown, Lorena E ^a   Zeng, Weiguang ^a  

^a Department of Civil and Environmental Engineering   (Australia)

Author keywords

Artificial proteins; Synthetic peptides; Vaccines

Indexed keywords

EPITOPE; INFLUENZA VACCINE; SYNTHETIC PEPTIDE; VACCINE;

ANIMAL EXPERIMENT; CONFERENCE PAPER; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; IMMUNOGENICITY; INFLUENZA VIRUS A; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODY FORMATION; B-LYMPHOCYTES; EPITOPES; FEMALE; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; T-LYMPHOCYTES; VACCINES, SYNTHETIC;

EID: 0032883926     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00205-4     Document Type: Conference Paper

References (28)

1. Anderer F. Preparation and properties of an artificial antigen immunologically related to tobacco mosaic virus. Biochem. Biophys. Acta. 71:1963;246-248.
2. Schutze M.P., Leclerc C., Jolivet M., Audibert F., Chedid L. Carrier-induced epitopic suppression, a major issue for future synthetic vaccines. J. Immunol. 135:1985;2319-2322.
3. DiJohn D., Torrese J.R., et al., Murillo J., et al., Herrington D.A., et al. Effect of priming with carrier on response to conjugate vaccine. Lancet. 2:1989;1415-1416.
4. Herzenberg L.A., Tokuhisa T., Herzenberg L.A. Carrier-priming leads to hapten-specific supression. Nature. 285:1980;664-665.
5. Leclerc C., Przewlocki G., Schutze M.P., Chedid L. A synthetic vaccine constructed by copolymerization of B- and T-cell determinants. Eur. J. Immunol. 17:1987;269-273.
6. Francis M.J., Hastings G.Z., Syred A.D., McGinn B., Brown F., Rowlands D.J. Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants. Nature. 330:1987;168-170.
7. Fitzmaurice C.J., Brown L.E., McInerney T.L., Jackson D.C. The assembly and immunological properties of non-linear synthetic immunogens containing T-cell and B-cell determinants. Vaccine. 14:1996;553-560.
8. Tam J.P. Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proc. Natl. Acad. Sci. USA. 85:1988;5409-5413.
9. Tam J.P., Lu Y.A. Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B-cell epitopes. Proc. Natl. Acad. Sci. USA. 86:1989;9084-9088.
10. Tam J.P., Spetzler J.C. Chemoselective approaches to the preparation of peptide dendrimers and branched artificial proteins using unprotected peptides as building blocks. Biomed. Pept. Proteins Nucleic Acids. 1:1995;123-132.
11. Rose K. Facile synthesis of homogeneous artificial proteins. J. Am. Chem. Soc. 116:1994;30-33.
12. Dawson P.E., Muir T.W., Clark-Lewis I., Kent S.B. Synthesis of proteins by native chemical ligation. Science. 266:1994;776-779.
13. Jackson D.C., Fitzmaurice C., Sheppard R.C., McMurray J., Brown L.E. Antigenic and immunogenic properties of synthetic peptide-based T-cell determinant polymers. Biomed. Pept. Proteins Nucleic Acids. 1:1995;171-176.
14. Jackson D.C., O'Brien-Simpson N., Ede N.J., Brown L.E. Free radical induced polymerization of synthetic peptides into polymeric immunogens. Vaccine. 15:1997;1697-1705.
15. O'Brien-Simpson N.M., Ede N.J., Brown L.E., Swan J., Jackson D.C. Polymerisation of unprotected synthetic peptides: a view towards synthetic peptide vaccines. J. Am. Chem. Soc. 119:1997;1183-1188.
16. Goddard P, McMurray JS, Sheppard RC, Emson P. A solulisable polymer support suitable for solid phase peptide synthesis and for injection into experimental animals. J Chem Soc Chem Commun 1988;1025-1027.
17. Mutter M., Tuchscherer G.G., Miller C., Altmann K.H., Carey R.I., Wyss D.F., Labhardt A.M., Rivier J.E. Template-assembled synthetic proteins with four-helix-bundle topology: total chemical synthesis and conformational studies. J. Am. Chem. Soc. 114:1992;1463-1470.
18. Jackson D.C., Tang X.L., Brown L.E., Murray J.M., White D.O., Tregear G.W. Antigenic determinants of influenza virus hemagglutinin. XII. The epitopes of a synthetic peptide representing the C-terminus of HA1. Virology. 155:1986;625-632.
19. Julius M.H., Simpson E., Herzenberg L.A. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 3:1973;645-649.
20. Ffrench R.A., Tang X.L., Anders E.M., Jackson D.C., White D.O., Drummer H., Wade J.D., Tregear G.W., Brown L.E. Class II-restricted T-cell clones to a synthetic peptide of influenza virus hemagglutinin differ in their fine specificities and in the ability to respond to virus. J. Virol. 63:1989;3087-3094.
21. Brown L.E., Stephens L., Jackson D.C. Synthetic peptide determinants for CD4+ T-cells as immunogens to study the importance of pre-existing helper T-cell immunity in influenza. Brown H.L.E., Webster R.G. Options for the control of influenza III. 1996;216-225 Elsevier, Amsterdam.
22. Rose K., Zeng W., Brown L.E., Jackson D.C. A synthetic peptide-based polyoxime vaccine construct of high purity and activity. Mol. Immunol. 32:1995;1031-1037.
23. Wiesmuller K.H., Jung G., Hess G. Novel low-molecular-weight synthetic vaccine against foot-and-mouth disease containing a potent B-cell and macrophage activator. Vaccine. 7:1989;29-33.
24. Deres K., Schild H., Wiesmuller K.H., Jung G., Rammensee H.G. In vivo priming of virus-specific cytotoxic T-lymphocytes with synthetic lipopeptide vaccine. Nature. 342:1989;561-564.
25. Zeng W., Jackson D.C., Rose K. Synthesis of a new template with a built-in adjuvant and its use in constructing peptide vaccine candidates through polyoxime chemistry. J. Pept. Sci. 2:1996;66-72.
26. Schoofs P.G., Geysen H.M., Jackson D.C., Brown L.E., Tang X.L., White D.O. Epitopes of an influenza viral peptide recognized by antibody at single amino acid resolution. J. Immunol. 140:1988;611-616.
27. Jackson D.C., Drummer H.E., Brown L.E. Conserved determinants for CD4+ T-cells within the light chain of the H3 hemagglutinin molecule of influenza virus. Virology. 198:1994;613-623.
28. Brown L.E., Ffrench R.A., Gawler J.M., Jackson D.C., Dyall-Smith M.L., Anders E.M., Tregear G.W., Duncan L., Underwood P.A., White D.O. Distinct epitopes recognized by I-Ad-restricted T-cell clones within antigenic site E on influenza virus hemagglutinin. J. Virol. 62:1988;305-312.